Best Peptides for Anti-Aging: What the Research Actually Supports

Start here

“Anti-aging” covers several different things: skin that looks older, cells that stop dividing, worn-out cells that linger and cause inflammation, mitochondria that slow down, an immune system that weakens. Different peptides aim at different pieces, and none aims at all of them.

The other thing to say up front: no peptide has been shown to make a human live longer or age slower. Some have evidence for one narrow piece. This guide grades each one on what has actually been tested and in what.

The peptides, ranked by evidence

1. GHK-Cu, for skin

The only entry with human trials for an aging outcome. GHK-Cu is a copper-carrying peptide your body makes, and levels fall with age. In small 12-week studies, a GHK-Cu face cream improved firmness, fine lines, and skin thickness compared with the same cream without it, and did as well as retinol at stimulating collagen. In rats it speeds wound healing. In cells it shifts thousands of genes toward a younger pattern, which is interesting and proves nothing about people (Pickart & Margolina, 2018).

Cream: small but real evidence. Injected: animal and lab data only, plus an open question about copper. Full page: GHK-Cu.

2. Epithalon, for telomeres

A four-amino-acid peptide from a Russian lab. In a dish it switches on telomerase, the enzyme that rebuilds the caps on chromosomes, and lets cells keep dividing. In mice and fruit flies it extended lifespan and restored melatonin. Nearly all of it comes from one research group, and there is no human trial for aging. Because cancers use telomerase to stay alive, whether switching it on is safe long-term is a real, unanswered question. Full page: epithalon.

3. FOXO4-DRI, for clearing old cells

Senescent cells are cells that have stopped dividing but refuse to die, and they leak inflammatory signals that damage tissue around them. FOXO4-DRI was designed to push those cells into dying. In one 2017 study, old and prematurely aged mice regained fur, fitness, and kidney function after treatment (Baar et al., 2017). It is one paper, in mice, and no human study has followed. Full page: FOXO4-DRI.

4. MOTS-c, for metabolism

A tiny peptide encoded in mitochondrial DNA, discovered in 2015. In mice it improved insulin sensitivity, prevented diet-induced obesity, and helped older animals exercise more. Levels in people fall with age, and a small trial of a synthetic version has looked at metabolic disease (Lee et al., 2015). Nothing yet on aging in humans. Full page: MOTS-c.

5. Thymosin alpha-1, for immune aging

The thymus, which trains immune cells, shrinks with age, and thymosin alpha-1 is one of its signals. It is used in some countries for hepatitis and as an immune booster, with real clinical data for those uses (Goldstein & Goldstein, 2009). Whether it slows immune aging in healthy older adults has not been tested. Full page: thymosin alpha-1.

6. BPC-157, for repair

Sold for aging on the theory that faster tissue repair is younger tissue. The animal data on healing is extensive; there is no human trial for anything, and none for aging. Full page: BPC-157.

7. Growth hormone peptides, indirectly

Ipamorelin, CJC-1295, sermorelin, and tesamorelin raise growth hormone, which falls with age. Restoring it improves body composition in trials of tesamorelin and MK-677, with modest effects on muscle. Growth hormone also raises IGF-1, and in animals, lower growth hormone signaling is linked to longer life, not shorter. The evidence that raising it in older adults extends anything is absent, and the blood-sugar and cancer questions are real. See the muscle growth guide.

What this means in practice

The evidence ladder is the whole story. One entry has human trials for an aging outcome, and it is a face cream. The rest are mouse results, one lab, or one paper. Read how peptides are studied before spending money on any of them.

Cream is not injection. GHK-Cu’s evidence is topical. Injecting it, or any of these, moves you from a small evidence base to none.

The boring things still win. Sleep, resistance training, not smoking, blood pressure and blood sugar under control, and a normal weight each have decades of human data on living longer. No peptide comes close, and none of them substitutes for those.

Safety is unmeasured. Long-term use of any of these has not been studied in people. The telomerase question for epithalon and the IGF-1 question for growth hormone peptides are the two that matter most. See the safety guide.

Frequently Asked Questions

Which anti-aging peptide has the most evidence?

GHK-Cu as a skin cream. Small human trials, decades of cosmetic use, a clear effect on skin. Nothing else on this list has a human trial for an aging outcome.

Can peptides reverse aging?

No study shows that in people. Mice on epithalon lived longer; mice on FOXO4-DRI got their fur back. Humans have not been tested.

Are they safe long term?

Unknown. Nobody has followed people on any of these for years. The two specific concerns are telomerase activation and cancer (epithalon) and high IGF-1 and cancer (growth hormone peptides).

Should I stack several?

Each one is untested alone in humans. Combining them multiplies the unknowns and makes it impossible to tell what did what. See the stacks guide.

What about rapamycin, metformin, and NAD+ precursors?

Different molecules, same problem: strong animal data, human longevity trials either running or not yet done. Rapamycin has the best animal record of anything; metformin’s human trial (TAME) has struggled for funding; NAD+ precursors raise NAD+ levels in people without a proven downstream benefit. None is a peptide, and none has more human aging evidence than the peptides above.

References

1. Pickart L, Margolina A. (2018). Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. PubMed
2. Baar MP, et al. (2017). Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging. Cell. PubMed
3. Lee C, et al. (2015). The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. PubMed
4. Goldstein AL, Goldstein AL. (2009). From lab to bedside: emerging clinical applications of thymosin alpha 1. Expert Opin Biol Ther. PubMed

See also

• Peptide
  BPC-157: What the Research Actually Shows About This Healing Peptide

  A plain review of the animal research on BPC-157, what it suggests about healing, and why none of it has been confirmed in people.

• Peptide
  GHK-Cu (Copper Peptide): Research, Mechanism, and Evidence for Tissue Repair

  GHK-Cu is a copper-carrying peptide your body makes naturally, studied mainly as a skin cream for aging skin and, in animals, for wound healing.

• Peptide
  Epithalon (Epitalon): Research, Mechanism, and a Careful Look at the Anti-Aging Evidence

  Epithalon is a four-amino-acid peptide from a Russian lab, studied for switching on telomerase and restoring melatonin. It lengthened telomeres in a dish and extended lifespan in mice, and it has never been tested for aging in people.